latest
DEAR ABBY: We live in a retirement community. Many of our friends have hearing loss that ranges from slight to profound. While most of them have the money to travel the globe, they don’t invest in hearing aids, which confounds us.
Read more
THE LIGHTEN’ BUG STORY…SHINE Last night as I woke up at 2AM to go to the bathroom, I didn’t turn on a light. I only had a night light. I noticed a “shiny” object on the floor. I thought it was a shadow caused by the night light, but it was too shiny. I imagined it moved, but then again it was 2 AM and I was sleepy, and it couldn’t be moving, could it?
Read more
SUNDAY, DECEMBER 17, 2023
Read moreOnce again, rumors persist this holiday season of a pernicious and evil campaign to cancel Christmas in Oklahoma’s public schools. In fact, I recently saw a social media post by our state superintendent pledging to protect Christmas (and guns?) in Oklahoma schools. As a former superintendent, I am thankful to hear this, and I am stepping forward as a fellow whistleblower to confirm that the plot to cancel Christmas in Oklahoma schools is much worse than anyone ever imagined. The ugly truth: your local school officials secretly canceled Christmas decades ago.
Read more
FRIDAY, DECEMBER 15, 2023
Read more
DEAR ABBY: After decades of research, I’m thrilled with the recent major progress being made in treatments for people who already have symptoms of Alzheimer’s disease. I’m hoping that, one day, we will be able to prevent people from developing memory impairment and dementia. Brain changes, including the buildup of a toxic protein into amyloid plaques, begin up to 20 years before a person notices any symptoms. This “asymptomatic” stage may be the perfect time to test treatments aiming to delay or prevent symptoms before they begin. This is why we are conducting the AHEAD Study, an investigational trial of lecanemab, an FDA-approved medication for mild cognitive impairment and mild dementia due to Alzheimer’s disease. The AHEAD Study is testing whether starting lecanemab in those with amyloid plaques BEFORE symptoms start can help prevent cognitive decline. As a neurologist, a clinical researcher and someone who has seen Alzheimer’s in my own family, I’m grateful we are seeing such progress in our field. But, Abby, we need help from your readers to test these promising medications before the devastating symptoms of Alzheimer’s disease are apparent. Those interested in the AHEAD Study should call 800-243-2370 or visit AHEADstudy.org to help us get ahead of Alzheimer’s. -- REISA SPERLING, M.D., PROFESSOR OF NEUROLOGY, HARVARD MEDICAL SCHOOL
Read more
WEDNESDAY, DECEMBER 13, 2023
Read more